Bank of America
TCRT icon

Bank of America’s Alaunos Therapeutics TCRT Stock Holding History

Bank of America’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-89
Closed -$287 – 6799
2025
Q4 		$287 Hold
89
– – ﹤0.01% 6647
2025
Q3 		$214 Buy
89
+4
+5% +$11 ﹤0.01% 7718
2025
Q2 		$412 Sell
85
-4
-4% -$12 ﹤0.01% 7709
2025
Q1 		$131 Sell
89
-49
-36% -$80 ﹤0.01% 7776
2024
Q4 		$263 Sell
138
-99
-42% -$220 ﹤0.01% 7532
2024
Q3 		$762 Buy
237
+71
+43% +$255 ﹤0.01% 7301
2024
Q2 		$1.16K Buy
166
+12
+8% +$143 ﹤0.01% 7210
2024
Q1 		$2.79K Sell
154
-231
-60% -$4.62K ﹤0.01% 7082
2023
Q4 		$4.04K Buy
385
+4
+1% +$48 ﹤0.01% 7045
2023
Q3 		$7.49K Sell
381
-107
-22% -$4.61K ﹤0.01% 6921
2023
Q2 		$37.3K Buy
488
+110
+29% +$8.9K ﹤0.01% 6549
2023
Q1 		$35.8K Sell
378
-65
-15% -$6.19K ﹤0.01% 6599
2022
Q4 		$43.1K Sell
443
-1,299
-75% -$188K ﹤0.01% 6524
2022
Q3 		$449K Buy
1,742
+1,628
+1,428% +$473K ﹤0.01% 5486
2022
Q2 		$21K Sell
114
-319
-74% -$30.5K ﹤0.01% 7172
2022
Q1 		$43K Sell
433
-5,057
-92% -$649K ﹤0.01% 7239
2021
Q4 		$897K Buy
5,490
+2,641
+93% +$580K ﹤0.01% 5396
2021
Q3 		$778K Buy
2,849
+236
+9% +$72.2K ﹤0.01% 5297
2021
Q2 		$1.03M Buy
2,613
+1,302
+99% +$608K ﹤0.01% 4874
2021
Q1 		$708K Sell
1,311
-1,433
-52% -$892K ﹤0.01% 5110
2020
Q4 		$1.04M Sell
2,744
-2,107
-43% -$838K ﹤0.01% 4471
2020
Q3 		$1.83M Buy
4,851
+4,020
+484% +$1.78M ﹤0.01% 3750
2020
Q2 		$409K Buy
831
+54
+7% +$24.1K ﹤0.01% 4763
2020
Q1 		$285K Buy
777
+104
+15% +$53.8K ﹤0.01% 4877
2019
Q4 		$477K Sell
673
-342
-34% -$235K ﹤0.01% 5039
2019
Q3 		$653K Sell
1,015
-449
-31% -$356K ﹤0.01% 4878
2019
Q2 		$1.28M Sell
1,464
-1,863
-56% -$1.28M ﹤0.01% 4394
2019
Q1 		$1.92M Buy
3,327
+3,017
+973% +$1.26M ﹤0.01% 4021
2018
Q4 		$88K Buy
310
+78
+34% +$30.8K ﹤0.01% 5984
2018
Q3 		$112K Sell
232
-432
-65% -$185K ﹤0.01% 5818
2018
Q2 		$301K Sell
664
-239
-26% -$152K ﹤0.01% 5189
2018
Q1 		$531K Buy
903
+669
+286% +$417K ﹤0.01% 4776
2017
Q4 		$146K Buy
234
+24
+11% +$17.2K ﹤0.01% 5566
2017
Q3 		$194K Buy
210
+45
+27% +$40K ﹤0.01% 5403
2017
Q2 		$153K Sell
165
-2,874
-95% -$2.82M ﹤0.01% 5428
2017
Q1 		$2.89M Sell
3,039
-250
-8% -$233K ﹤0.01% 3543
2016
Q4 		$2.64M Buy
3,289
+2,417
+277% +$2.18M ﹤0.01% 3531
2016
Q3 		$737K Buy
872
+57
+7% +$45.8K ﹤0.01% 4371
2016
Q2 		$671K Buy
815
+119
+17% +$130K ﹤0.01% 4458
2016
Q1 		$774K Sell
696
-1,131
-62% -$1.16M ﹤0.01% 4289
2015
Q4 		$2.28M Sell
1,827
-958
-34% -$1.58M ﹤0.01% 3691
2015
Q3 		$3.76M Sell
2,785
-561
-17% -$926K ﹤0.01% 3166
2015
Q2 		$6.02M Buy
3,346
+2,319
+226% +$3.6M ﹤0.01% 2404
2015
Q1 		$1.66M Buy
1,027
+292
+40% +$433K ﹤0.01% 3396
2014
Q4 		$559K Buy
735
+436
+146% +$231K ﹤0.01% 4540
2014
Q3 		$118K Sell
299
-286
-49% -$138K ﹤0.01% 5867
2014
Q2 		$353K Buy
585
+506
+641% +$282K ﹤0.01% 4969
2014
Q1 		$54K Sell
79
-4
-5% -$2.68K ﹤0.01% 6371
2013
Q4 		$54K Buy
83
+10
+14% +$5.96K ﹤0.01% 6516
2013
Q3 		$43K Sell
73
-22
-23% -$9.91K ﹤0.01% 6511
2013
Q2 		$30K Buy
+95
New +$26.4K ﹤0.01% 6809

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America's TCRT Position: Q1 2026 in Review

Bank of America sold out of Alaunos Therapeutics (TCRT) in Q1 2026, closing a stake of 89 shares — an estimated $287 sold.

Bank of America first reported a position in TCRT in Q2 2013 and held it in 51 quarters. The position peaked at $6.02M in Q2 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Bank of America reported no remaining Alaunos Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 89 Alaunos Therapeutics shares in Q1 2026, an estimated $287.
  • Bank of America first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 51 quarters.
  • Bank of America's Alaunos Therapeutics position peaked at $6.02M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.